US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2036 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BR10010a, Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replacing BR10010
BR2082, Breast disease spectrum (breast cancer progression) tissue array, 206 cases/208 cores
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
ME1003, Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004

Newly added tissue microarrays in recent month:

2014-10-15 FDA996, Multiple organ normal tissue array, 51 cases/99 cores, replacing FDA995
2014-10-15 MC5003b, High-density multiple organ tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 500 cases/500 cores, replacing MC5003a
2014-09-30 FBN406c, Frozen multiple organ normal tissue array, 20 organs/40 cores, replacing FBN406b
2014-09-22 FCY301, Multiple organ normal tissue array of cynomolgus monkey, 15 organs/30 cores
2014-09-19 BN02014, Esophagus tissue array with esophagus cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/ 80 cores
2014-09-15 BR1503d, Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replacing BR1503c
2014-09-15 PA961b, Pancreas cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases/96 cores, replacing PA961a
2014-09-12 PR483b, Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing PR483a
2014-09-09 BR243r, Breast cancer tissue array with matched adjacent breast tissue as control, including TNM, clinical stage and pathology grade, 6 cases/ 24 cores, replacing BR243q
2014-09-01 HLiv_HCC180Sur_02, Hepatocellular carcinoma tissue array (90 cases) and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 PA807, Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/ 80 cores
2014-09-01 HPan-Ade180Sur-01, Pancreatic cancer tissue array, 90 cases of and matched normal adjacent tissue (NAT, 1 core/case), with survival data
2014-09-01 HRec-Ade180Sur-01, Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data
2014-09-01 HCol-Ade180Sur-03, Colon cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HGEj-Ade130Sur-01, Gastroesophageal junctional cancer tissue array, 65 cases and matched normal adjacent tissue, with survival data
2014-09-01 HLiv-HCC180Sur-03, Liver cancer tissue array (90 cases) and normal adjacent tissue (NAT), 1 core/case, with survival data
2014-09-01 HLug-Ade150Sur-02, Lung adenocarcinoma tissue array (75 cases) and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HLug-Squ150Sur-02, Lung squamous cell carcinoma tissue array (75 cases) and matched normal adjacent tissue (NAT, 1 core/case), with survival data
2014-09-01 HRaU-Uro120Sur-01, Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data
2014-09-01 HRec-Ade180Sur-02, Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data